# A support vector machine-based tool for rapid pediatric asthma exacerbation risk assessment: development and nursing application

## TL;DR

This paper introduces a new tool using machine learning to quickly assess asthma risk in children, improving efficiency and patient satisfaction in nursing care.

## Contribution

A novel SVM-based tool (PARRT) for rapid pediatric asthma exacerbation risk assessment with real-time clinical application.

## Key findings

- The SVM model achieved an AUC of 0.9998, indicating high predictive accuracy.
- PARRT reduced patient and report wait times while improving satisfaction and nursing efficiency.

## Abstract

Childhood asthma poses a significant threat to pediatric health, and traditional assessment methods are often inadequate in efficiency and accuracy. This study aims to develop a rapid assessment tool for pediatric asthma exacerbation risk based on the support vector machine (SVM) algorithm and evaluate its value in nursing practice.

Clinical data from children with asthma were collected, incorporating key indicators including eczema, allergic rhinitis (AR), family medical history (FMH), dyspnea, white blood cell count (WBC), immunoglobulin E (IgE), and fractional exhaled nitric oxide (FeNO). An SVM-based risk prediction model was developed. Utilizing Plumber, an application programming interface (API) was constructed to enable data transmission and real-time risk assessment. The pediatric asthma risk rapid tool (PARRT) mini-program was subsequently developed. Service quality metrics were compared before and after PARRT implementation.

The constructed SVM model demonstrated excellent performance on the test dataset, achieving an area under the curve (AUC) of 0.9998. Clinical application revealed that PARRT significantly reduced patient wait time, decreased report wait time, improved satisfaction scores among patients and their families, as well as enhanced nursing staff efficiency.

PARRT exhibits strong predictive accuracy and holds considerable promise for clinical utility in pediatric asthma management.